Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/17425247.2018.1378642PMID 28895435PMCID PMC5847369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy

  2017cited by this paper
• Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors

  2017cited by this paper
• Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors

  2017cited by this paper
• Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma

  2016cited by this paper
• Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment

  2016influential reference
• Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.

  2016cited by this paper
• Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma

  2016influential reference
• Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.

  2016cited by this paper
• Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.

  2016cited by this paper
• Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.

  2015cited by this paper
• Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions

  2015cited by this paper
• Neural Stem Cells Secreting Anti‐HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases

  2015influential reference
• Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis.

  2015cited by this paper
• Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model

  2015cited by this paper
• Temozolomide nanoparticles for targeted glioblastoma therapy.

  2015cited by this paper
• Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice.

  2015cited by this paper
• Integrin α4 is involved in the regulation of glioma-induced motility of bone marrow mesenchymal stem cells.

  2015cited by this paper
• Intranasal Delivery of Bone Marrow Mesenchymal Stem Cells Improved Neurovascular Regeneration and Rescued Neuropsychiatric Deficits after Neonatal Stroke in Rats

  2015cited by this paper
• Intranasal delivery of stem cells as therapy for central nervous system disease.

  2015cited by this paper
• Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration

  2015cited by this paper
• Intranasal Delivery of Therapeutic Neural Stem Cells to Target Intracerebral Glioma

  2015cited by this paper
• Mesenchymal Stem Cells from Human Fat Engineered to Secrete BMP4 Are Nononcogenic, Suppress Brain Cancer, and Prolong Survival

  2014influential reference
• Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo

  2014cited by this paper
• Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth.

  2014cited by this paper
• Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells

  2014cited by this paper
• Intranasal Delivery of Bone Marrow-Derived Mesenchymal Stem Cells, Macrophages, and Microglia to the Brain in Mouse Models of Alzheimer's and Parkinson's Disease

  2014cited by this paper
• Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity.

  2014cited by this paper
• TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling.

  2014cited by this paper
• Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors.

  2014influential reference
• Functional nanoparticles in targeting glioma diagnosis and therapies.

  2014cited by this paper
• VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System

  2014cited by this paper
• Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.

  2014influential reference
• Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction

  2014influential reference
• Recent advances in delivery through the blood-brain barrier.

  2014cited by this paper
• Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.

  2013cited by this paper
• Magnetic Resonance Imaging Tracking of Ferumoxytol‐Labeled Human Neural Stem Cells: Studies Leading to Clinical Use

  2013cited by this paper
• DNA Nanocarriers for Systemic Administration: Characterization and In Vivo Bioimaging in Healthy Mice

  2013cited by this paper
• Immunotherapeutics for breast cancer

  2013cited by this paper
• Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery.

  2013cited by this paper
• Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer

  2013cited by this paper
• Near-infrared optical imaging of nucleic acid nanocarriers in vivo.

  2013cited by this paper
• Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.

  2013cited by this paper
• Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells

  2013cited by this paper
• Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies

  2013cited by this paper
• Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

  2012cited by this paper
• Induction of apoptosis in glioma cells and upregulation of Fas expression using the human interferon-β gene.

  2012cited by this paper
• Intranasal Delivery of Neural Stem/Progenitor Cells: A Noninvasive Passage to Target Intracerebral Glioma

  2012influential reference
• Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.

  2012cited by this paper
• Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and Immunogenicity

  2012cited by this paper
• Size matters: gold nanoparticles in targeted cancer drug delivery.

  2012cited by this paper
• Olfactory route for cerebrospinal fluid drainage into the cervical lymphatic system in a rabbit experimental model

  2012cited by this paper
• Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson’s disease

  2012cited by this paper
• Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1

  2011cited by this paper
• Comparative anatomy and histology : a mouse and human atlas

  2011cited by this paper
• Interferon: Current Status and Future Prospects in Cancer Therapy

  2011cited by this paper
• Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells as Cellular Delivery Vehicles for Prodrug Gene Therapy of Glioblastoma

  2011cited by this paper
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011cited by this paper
• Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy.

  2011cited by this paper
• Stem cell technology for neurodegenerative diseases

  2011cited by this paper
• Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

  2011cited by this paper
• Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.

  2010cited by this paper
• Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model.

  2010cited by this paper
• Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage

  2010cited by this paper
• Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma

  2010cited by this paper
• Biodegradable polymeric nanoparticles based drug delivery systems.

  2010cited by this paper
• Treatment of HER2-overexpressing breast cancer.

  2010cited by this paper
• Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro.

  2010cited by this paper
• Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors

  2010cited by this paper
• Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells

  2009cited by this paper
• Antibody-based therapy of leukaemia

  2009cited by this paper
• Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo

  2009influential reference
• Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds

  2009cited by this paper
• Convection-enhanced delivery for the treatment of brain tumors

  2009cited by this paper
• Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas.

  2009cited by this paper
• Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

  2009cited by this paper
• Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.

  2009influential reference
• Genetic modification of mesenchymal stem cells to express a single‐chain antibody against EGFRvIII on the cell surface

  2009cited by this paper
• Intranasal delivery of cells to the brain.

  2009cited by this paper
• Preparation of biodegradable polymer nanoparticles by miniemulsion technique and their cell interactions.

  2008cited by this paper
• Delivery of interferon-beta to the monkey nervous system following intranasal administration.

  2008cited by this paper
• Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting

  2008cited by this paper
• Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.

  2008cited by this paper
• Optimization of a gene electrotransfer method for mesenchymal stem cell transfection

  2008cited by this paper
• Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia

  2008cited by this paper
• Systemic Vesicular Stomatitis Virus Selectively Destroys Multifocal Glioma and Metastatic Carcinoma in Brain

  2008cited by this paper
• Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

  2008cited by this paper
• In Vitro Model of Bromodeoxyuridine or Iron Oxide Nanoparticle Uptake by Activated Macrophages from Labeled Stem Cells: Implications for Cellular Therapy

  2008cited by this paper
• Cell vehicle targeting strategies

  2008cited by this paper
• Intranasal administration delivers peptoids to the rat central nervous system.

  2008cited by this paper
• Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma

  2008influential reference
• Convection-enhanced delivery for treatment of brain tumors

  2007cited by this paper
• Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines

  2007cited by this paper
• Bone marrow stem cell imaging after intracoronary administration.

  2007cited by this paper
• Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites.

  2007cited by this paper
• Stem cell transplantation: the lung barrier.

  2007cited by this paper
• Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.

  2007cited by this paper
• The Nose Revisited: A Brief Review of the Comparative Structure, Function, and Toxicologic Pathology of the Nasal Epithelium

  2006cited by this paper
• Erratum: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas (Cancer Research (April 15, 2005) 65 (3307-3318))

  2006cited by this paper

• Nasal Nanotherapeutics for Central Nervous System Disorders: Bridging the Translational Gap in Central Nervous System Drug Delivery.

  2025cites this paper
• Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Nose-to-brain delivery of human muse cells enhances structural and functional recovery in the murine ischemic stroke model

  2025cites this paper
• Nanosystems at Nexus: Navigating Nose-to-Brain Delivery for Glioblastoma Treatment.

  2025cites this paper
• Nanoparticle-Mediated Nose-to-Brain Delivery for Ischemic Stroke Therapy: Preclinical Insights

  2025cites this paper
• Endothelial progenitor cells and their secretome for stroke therapy: a narrative review

  2025cites this paper
• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• Intranasal Wharton's Jelly‐Derived Mesenchymal Stem Cell Therapy, Alone or in Conjunction With Therapeutic Hypothermia, Alleviates Neonatal Hypoxic‐Ischemic Brain Injury in Mice

  2025cites this paper
• Effect of Intranasal Administration of Adipose-Derived Mesenchymal Stem Cells on Acute Demyelination in Mouse Corpus Callosum

  2024cites this paper
• In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route

  2024cites this paper
• Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway.

  2024cites this paper
• Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off‐the‐shelf versatile tumor delivery vehicle

  2024cites this paper
• Clinical state and future directions of stem cell therapy in stroke rehabilitation.

  2024cites this paper
• Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders

  2023cites this paper
• Intranasal delivery of stem cells labeled by nanoparticles in neurodegenerative disorders: Challenges and opportunities.

  2023cites this paper
• The Development of Drug Delivery Systems for Efficient Intracranial Hemorrhage Therapy

  2023cites this paper
• Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients

  2023cites this paper
• Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies

  2023cites this paper
• Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies

  2023cites this paper
• Long-Acting Therapeutic Delivery Systems for the Treatment of Gliomas.

  2023cites this paper
• Bone marrow mesenchymal stem cells improve cognitive impairments induced by methamphetamine in rats and reduce relapse

  2022cites this paper
• Mesenchymal stem cells for the treatment of cognitive impairment caused by neurological diseases

  2022cites this paper
• Delivery strategies for cell-based therapies in the brain: overcoming multiple barriers

  2021cites this paper
• Intranasal drug delivery: opportunities and toxicologic challenges during drug development

  2021cites this paper
• Advances in intranasal application of stem cells in the treatment of central nervous system diseases

  2021cites this paper
• Stem cells for the treatment of glioblastoma: a 20-year perspective

  2021cites this paper
• Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine

  2021cites this paper
• Mesenchymal stem/stromal cells as next-generation drug delivery vehicles for cancer therapeutics

  2021influential citation
• Nose-to-brain delivery of biologics and stem cells

  2021cites this paper
• Recent advances in stem cell therapy for neurodegenerative disease: Three dimensional tracing and its emerging use

  2021cites this paper
• Intranasal administration of mitochondria improves spatial memory in olfactory bulbectomized mice

  2021cites this paper
• Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.

  2021cites this paper
• Review article: Paracrine effects of Transplanted Neural stem cells in Ischemic strokes

  2021cites this paper
• Review Imaging of intranasal drug delivery to the brain

  2020cites this paper
• Nose ‐To ‐Brain Delivery of Mitochondria for Treatment of Parkinson’s Disease Model Rats With 6-Hydroxydopamine

  2020cites this paper
• Drug Delivery Approaches and Imaging Techniques for Brain Tumor

  2020cites this paper
• Harnessing Human Stem Cells for the Treatment of Glioblastoma – Twenty Year Perspective – Review of Preclinical and Clinical Studies: 2000–2020

  2020cites this paper
• Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation

  2020cites this paper
• The therapeutic potential of exogenous adult stem cells for the injured central nervous system

  2020cites this paper
• Locoregional delivery of stem cell–based therapies

  2020cites this paper
• Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine.

  2020cites this paper
• Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo

  2020cites this paper
• Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management

  2020cites this paper
• Review on clinical trial results of red and near infrared LED photobiomodulation

  2020cites this paper
• Imaging of intranasal drug delivery to the brain.

  2020cites this paper
• Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects

  2020cites this paper
• Optimizing Stem Cell Therapy after Ischemic Brain Injury

  2020influential citation
• Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects

  2019cites this paper
• Modern Concepts in Regenerative Therapy for Ischemic Stroke: From Stem Cells for Promoting Angiogenesis to 3D-Bioprinted Scaffolds Customized via Carotid Shear Stress Analysis

  2019cites this paper
• Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson’s disease therapy

  2019cites this paper
• Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke.

  2019cites this paper
• The effect of intranasally administered TLR3 agonist larifan on metabolic profile of microglial cells in rat with C6 glioma

  2018cites this paper
• Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report

  2018cites this paper
• Feasibility of Mitochondrial Transplantation Via Nose‐To‐Brain Delivery for Treatment of Parkinson Diseases

  2018cites this paper